skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Update on the rational use of (90)Y-ibritumomab tiuxetan in the treatment of follicular lymphoma

Review

(2034) Views  (551) Full article downloads

Authors: Martina Lehnert, Heinz Ludwig, Niklas Zojer

Published Date July 2009 Volume 2009:2 Pages 199 - 208
DOI: http://dx.doi.org/10.2147/OTT.S3975

Martina Lehnert, Heinz Ludwig, Niklas Zojer

1st Department of Medicine, Center for Oncology and Hematology, Wilhelminenspital, Vienna, Austria

Abstract: The development of radiolabeled antibodies against CD20 has facilitated targeted treatment of follicular lymphoma (FL). By using 90Y-ibritumomab tiuxetan (Zevalin®), a radionuclide (yttrium-90, linked by the chelator tiuxetan to the antibody ibritumomab) is brought into the vicinity of lymphoma cells. By the so-called cross-fire effect, this beta emitter has the capacity to destroy not only the lymphoma cells having bound the antibody, but also neighboring lymphoma cells. Currently this antibody is licensed in the European Union for use in relapsed or refractory FL. It is anticipated that this drug will also be approved for use as consolidation therapy after successful first-line treatment. Here we first will review the published literature supporting the use of 90Y-ibritumomab tiuxetan in the aforementioned indications and emerging data showing applicability of ibritumomab tiuxetan as sole first-line therapy for FL, as well as in the transplant setting. Possible strategies of incorporating ibritumomab tiuxetan into the treatment algorithm of FL are discussed.

Keywords: follicular lymphoma, 90Y-ibritumomab tiuxetan








Readers of this article also read:

Role of trabectedin in the treatment of soft tissue sarcoma
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
The pathophysiology of bronchiectasis
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
Health literacy and health seeking behavior among older men in a middle-income nation
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy